+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurovascular Devices Market - Global Forecast 2026-2032- Product Image
Neurovascular Devices Market - Global Forecast 2026-2032- Product Image
Sale

Neurovascular Devices Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454977
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurovascular Devices Market is projected to reach USD 6.01 Billion in 2026. It is expected to continue growing at a CAGR of 7.57%, reaching USD 9.33 Billion by 2032.

Neurovascular devices support the diagnosis and endovascular treatment of ischemic stroke, intracranial aneurysms, arteriovenous malformations, carotid artery disease, and other cerebrovascular disorders. Demand is tied to a clear clinical need: the World Stroke Organization reports more than 12 million new strokes annually worldwide, and stroke remains one of the leading causes of death and long-term disability.

The market is shaped by mechanical thrombectomy devices, aspiration catheters, stent retrievers, embolic coils, flow diverters, intracranial stents, guidewires, microcatheters, and access systems. Growth is increasingly evidence-led, with hospitals prioritizing devices that improve recanalization, reduce procedure time, support distal access, and align with guideline-based stroke and aneurysm care.

Transformative Shifts in Neurovascular Care

The neurovascular devices landscape is moving from procedure-specific tools toward integrated stroke and aneurysm care platforms. Randomized clinical trials have established mechanical thrombectomy as standard care for eligible large vessel occlusion stroke, expanding investment in comprehensive stroke centers, rapid imaging, and hub-and-spoke referral networks.

A second shift is the rise of next-generation aneurysm treatment, including lower-profile flow diverters, intrasaccular devices, and adjunctive coil technologies. At the same time, regulatory expectations for real-world evidence, post-market surveillance, and device traceability are increasing, especially in the United States and European Union.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming cumulative rather than isolated in neurovascular care. FDA-cleared and CE-marked AI tools already support CT, CTA, and perfusion imaging triage for suspected large vessel occlusion, helping stroke teams prioritize time-sensitive transfers and treatment decisions.

The larger opportunity is workflow orchestration. AI can connect image interpretation, emergency alerts, catheter lab readiness, inventory planning, and outcomes tracking. Industry leaders must validate algorithms across diverse populations because stroke presentation, scanner protocols, and access to thrombectomy-capable centers vary significantly by region.

Regional Insights Across Global Markets

North America remains a high-adoption region for neurovascular devices, supported by established stroke networks, FDA pathways, reimbursement infrastructure, and a large installed base of advanced CT, MRI, and angiography imaging. Europe shows strong demand through comprehensive stroke centers, aneurysm programs, and guideline-driven thrombectomy pathways, while the EU Medical Device Regulation raises evidence, clinical evaluation, post-market surveillance, and compliance requirements for neurointerventional products.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in stroke systems, specialist training, emergency imaging, and neurointerventional capacity to address a substantial cerebrovascular disease burden. Latin America is gaining traction through tertiary hospitals and public-private investments, with Mexico and Brazil anchoring procedural demand; however, reimbursement gaps and regional disparities continue to affect access. The Middle East benefits from healthcare infrastructure development and demand for advanced stroke and aneurysm care, particularly in high-investment health systems, while Africa presents long-term need-driven opportunity constrained by limited 24/7 neurointerventional services, workforce shortages, and uneven imaging availability.

Strategic Group Insights

ASEAN markets are strengthening stroke care capacity through public hospital investment, regional centers of excellence, and expanding access to CT angiography and catheterization infrastructure, though adoption varies by reimbursement and specialist availability. The GCC benefits from high healthcare spending, medical city development, and demand for premium neurointerventional systems, with procurement increasingly linked to clinical outcomes, physician training, and international accreditation standards. The European Union remains influential through MDR compliance, health technology assessment, clinical evidence expectations, and cross-border standards for device safety, traceability, and post-market performance.

BRICS countries represent scale-driven opportunity where stroke burden is high, hospital modernization is ongoing, and local manufacturing or localization policies influence procurement and regulatory strategy. G7 markets emphasize premium innovation, randomized and real-world evidence, functional outcome improvement, and reimbursement value for thrombectomy, aneurysm embolization, and flow diversion technologies. NATO countries overlap substantially with advanced hospital infrastructure and emergency care systems, but neurovascular device purchasing still differs by national health system design, budget cycles, tender processes, and domestic clinical priorities.

Country-Level Neurovascular Device Insights

The United States leads in FDA-cleared stroke treatment devices, mechanical thrombectomy adoption, advanced imaging use, and neurovascular clinical trial activity, while Canada emphasizes organized stroke systems, evidence-based procurement, and coordinated care pathways across provincial health networks. Mexico and Brazil offer growth through tertiary hospitals, expanding private healthcare capacity, and rising stroke awareness, though reimbursement limitations and regional disparities affect timely access to neurointerventional treatment.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support advanced neurovascular care through specialized stroke centers, aneurysm programs, national or regional thrombectomy pathways, and clinical guideline adoption. Germany and France benefit from strong hospital infrastructure and procedural expertise, the United Kingdom continues to expand thrombectomy access through organized stroke networks, and Italy and Spain show demand from established neurology and interventional neuroradiology centers. Russia faces access variability linked to geography, infrastructure, and specialist distribution.

China, India, Japan, Australia, and South Korea are central to Asia-Pacific neurovascular device growth, driven by aging populations, high stroke burden, rising awareness, emergency imaging expansion, and regulatory modernization. China is advancing stroke center development and domestic device capability, India is expanding tertiary neurointervention services amid significant access gaps, Japan has mature endovascular expertise supported by an aging population, Australia benefits from coordinated stroke systems across major cities, and South Korea combines advanced hospital infrastructure with strong adoption of image-guided neurointerventional care.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical differentiation over device breadth alone. Evidence on first-pass effect, complete reperfusion, complication reduction, aneurysm occlusion durability, retreatment reduction, and long-term functional outcomes is essential for payer acceptance, hospital purchasing, and guideline-aligned adoption.

Companies should pair device innovation with physician training, AI-enabled workflow partnerships, and service models that improve door-to-imaging, door-to-puncture, and reperfusion timelines. Regional strategies must address reimbursement, local regulatory evidence, health technology assessment, physician education, tender requirements, and supply resilience for catheters, coils, stents, flow diverters, and thrombectomy systems.

Research Methodology

This executive summary is based on a structured research approach using verified public sources, including World Health Organization and World Stroke Organization disease-burden data, FDA device databases, clinical trial registries, peer-reviewed stroke and neurointervention literature, clinical practice guidelines, and regional regulatory guidance.

Market interpretation combines secondary research with industry benchmarking across product categories, care settings, reimbursement environments, regulatory pathways, and adoption barriers. Insights are validated through consistency checks across clinical guidelines, regulatory records, hospital procurement trends, technology adoption patterns, and publicly available healthcare infrastructure indicators.

Conclusion: Evidence-Led Growth Outlook

The neurovascular devices market is positioned for sustained evidence-led growth as stroke systems mature, aneurysm technologies advance, and AI improves triage and workflow coordination. The strongest opportunities will favor devices that demonstrate measurable clinical value and fit seamlessly into emergency neurovascular pathways.

Future competitiveness will depend on regulatory readiness, real-world outcomes, physician training, reimbursement alignment, and regional access strategies. Companies that combine innovation with data, service support, and equitable market expansion will be best placed to lead in neurovascular intervention.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurovascular Devices Market, by Product Type
7.1. Introduction
7.2. Embolization Devices
7.2.1. Coil Embolization Devices
7.2.2. Liquid Embolic Systems
7.2.3. Flow Diversion Stents
7.3. Angioplasty & Stenting Systems
7.4. Neurothrombectomy Devices
7.4.1. Stent Retrievers
7.4.2. Aspiration/Suction Devices
7.4.3. Mechanical Clot Retrievers/Snares
7.4.4. Hybrid Devices
7.5. Support & Access Devices
7.5.1. Microcatheters
7.5.2. Guidewires
7.5.3. Balloon Catheters
8. Neurovascular Devices Market, by Indication
8.1. Introduction
8.2. Cerebral Aneurysms
8.3. Ischemic Stroke
8.4. Arteriovenous Malformations (AVMs) & Fistulas
8.5. Carotid Artery & Intracranial Stenosis
8.6. Hemorrhagic Stroke
9. Neurovascular Devices Market, by Clinical Procedure
9.1. Introduction
9.2. Mechanical Thrombectomy
9.3. Aneurysm Occlusion
9.4. Flow Diversion
9.5. Carotid Artery Stenting (CAS)
9.6. Intracranial Stenting
10. Neurovascular Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Hospital Affiliated Centers
10.2.2. Independent Centers
10.3. Hospitals
10.4. Specialty Clinics
10.5. Research Laboratories & Academic Institutions
11. Neurovascular Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Online Sales
11.4. Third Party Distributors
12. Neurovascular Devices Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Europe
12.4. Latin America
12.5. Middle East
12.6. Africa
13. Neurovascular Devices Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Neurovascular Devices Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Canada
14.5. Japan
14.6. India
14.7. United Kingdom
14.8. Brazil
14.9. France
14.10. Mexico
14.11. South Korea
14.12. Australia
14.13. Italy
14.14. Spain
14.15. Russia
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Stryker Corporation
16.2. Medtronic plc
16.3. Johnson & Johnson
16.4. Penumbra, Inc.
16.5. Terumo Corporation
16.6. Kaneka Corporation
16.7. BALT Group
16.8. MicroPort Scientific Corporation
16.9. ASAHI INTECC CO., LTD.
16.10. Koninklijke Philips N.V.
16.11. Endologix Inc.
16.12. Integer Holdings Corporation
16.13. Secant Group, LLC by Solesis Group
16.14. Imperative Care, Inc.
16.15. Medical Murray, Inc.
16.16. Phenox GmbH
16.17. Zeus Company LLC
16.18. Acandis GmbH
16.19. Rapid Medical Ltd.
16.20. Sino Medical Sciences Technology Inc.
16.21. NeuroSafe Medical Co., Ltd.
16.22. Scientia Vascular, Inc.
16.23. Anaconda Biomed S.L.
16.24. ArtVentive Medical Group, Inc.
16.25. Evasc Medical Systems Corp
16.26. InspireMD Inc.
16.27. iVascular S.L.U.
16.28. MIVI Neuroscience, Inc.
16.29. NeuroVasc Technologies Inc.
16.30. Nventric, Inc.
16.31. Q'Apel Medical Inc.
16.32. Radical Catheter Technologies, Inc.
16.33. Route 92 Medical, Inc.
16.34. Vesalio, LLC
16.35. Wallaby Medical Holding, Inc..
16.36. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
List of Figures
FIGURE 1. GLOBAL NEUROVASCULAR DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEUROVASCULAR DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEUROVASCULAR DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEUROVASCULAR DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL EMBOLIZATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COIL EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COIL EMBOLIZATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COIL EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LIQUID EMBOLIC SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LIQUID EMBOLIC SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LIQUID EMBOLIC SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FLOW DIVERSION STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL FLOW DIVERSION STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL FLOW DIVERSION STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL STENT RETRIEVERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL STENT RETRIEVERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL STENT RETRIEVERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ASPIRATION/SUCTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ASPIRATION/SUCTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ASPIRATION/SUCTION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MECHANICAL CLOT RETRIEVERS/SNARES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MECHANICAL CLOT RETRIEVERS/SNARES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MECHANICAL CLOT RETRIEVERS/SNARES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL HYBRID DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HYBRID DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HYBRID DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SUPPORT & ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SUPPORT & ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SUPPORT & ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MICROCATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MICROCATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MICROCATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL GUIDEWIRES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL GUIDEWIRES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BALLOON CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BALLOON CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BALLOON CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CEREBRAL ANEURYSMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CEREBRAL ANEURYSMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CEREBRAL ANEURYSMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ARTERIOVENOUS MALFORMATIONS (AVMS) & FISTULAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ARTERIOVENOUS MALFORMATIONS (AVMS) & FISTULAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ARTERIOVENOUS MALFORMATIONS (AVMS) & FISTULAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CAROTID ARTERY & INTRACRANIAL STENOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CAROTID ARTERY & INTRACRANIAL STENOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CAROTID ARTERY & INTRACRANIAL STENOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL FLOW DIVERSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL FLOW DIVERSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL FLOW DIVERSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CAROTID ARTERY STENTING (CAS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CAROTID ARTERY STENTING (CAS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CAROTID ARTERY STENTING (CAS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL INTRACRANIAL STENTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL INTRACRANIAL STENTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL INTRACRANIAL STENTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITAL AFFILIATED CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITAL AFFILIATED CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITAL AFFILIATED CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL INDEPENDENT CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL INDEPENDENT CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL INDEPENDENT CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL RESEARCH LABORATORIES & ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL RESEARCH LABORATORIES & ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL RESEARCH LABORATORIES & ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 128. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 130. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 131. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 132. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 133. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 134. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 135. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 136. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 137. EUROPE NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 158. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 160. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 161. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 162. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 163. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 164. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 165. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 167. AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 172. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 173. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 174. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 175. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 176. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 178. NATO NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 179. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 182. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 183. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 184. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 185. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 186. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 188. G7 NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 189. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 192. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 193. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 194. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 195. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 196. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 198. BRICS NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 209. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 211. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 212. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 213. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 214. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 215. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 216. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 218. ASEAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 219. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 221. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 222. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 223. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 224. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 225. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 226. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 228. GCC NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 229. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 234. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 235. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 236. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 237. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 239. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. CHINA NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 241. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 243. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 244. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 245. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 246. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 247. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 249. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 250. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 251. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 252. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 253. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 254. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 255. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 256. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 257. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 259. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 260. CANADA NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 263. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 264. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 265. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 266. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 267. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 269. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 272. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 273. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 274. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 275. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 276. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 277. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 279. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 280. INDIA NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 283. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 284. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 285. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 286. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 287. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 289. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 294. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 310. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 311. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 312. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 313. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 314. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 315. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 316. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 317. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 319. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 320. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 323. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 324. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 325. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 326. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 327. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 329. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 330. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 331. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 332. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, 2017-2032 (USD MILLION)
TABLE 333. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2017-2032 (USD MILLION)
TABLE 334. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT & ACCESS DEVICES, 2017-2032 (USD MILLION)
TABLE 335. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 336. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CLINICAL PROCEDURE, 2017-2032 (USD MILLION)
TABLE 337. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 338. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 339. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 340. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 341. AUSTRALIA NEUROVASCULAR DEVICES

Companies Mentioned

  • Stryker Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Penumbra, Inc.
  • Terumo Corporation
  • Kaneka Corporation
  • BALT Group
  • MicroPort Scientific Corporation
  • ASAHI INTECC CO., LTD.
  • Koninklijke Philips N.V.
  • Endologix Inc.
  • Integer Holdings Corporation
  • Secant Group, LLC by Solesis Group
  • Imperative Care, Inc.
  • Medical Murray, Inc.
  • Phenox GmbH
  • Zeus Company LLC
  • Acandis GmbH
  • Rapid Medical Ltd.
  • Sino Medical Sciences Technology Inc.
  • NeuroSafe Medical Co., Ltd.
  • Scientia Vascular, Inc.
  • Anaconda Biomed S.L.
  • ArtVentive Medical Group, Inc.
  • Evasc Medical Systems Corp
  • InspireMD Inc.
  • iVascular S.L.U.
  • MIVI Neuroscience, Inc.
  • NeuroVasc Technologies Inc.
  • Nventric, Inc.
  • Q'Apel Medical Inc.
  • Radical Catheter Technologies, Inc.
  • Route 92 Medical, Inc.
  • Vesalio, LLC
  • Wallaby Medical Holding, Inc..
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.01 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.33 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report - Product Image

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report

  • Report
  • 198 Pages
  • Global
From
Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 - Product Image

Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034

  • Report
  • 146 Pages
  • Global
From
Neurovascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Neurovascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Neurovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Neurovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Neurovascular Devices Market Size, Share & Trends Analysis Report by Device, Therapeutic Applications, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Neurovascular Devices Market Size, Share & Trends Analysis Report by Device, Therapeutic Applications, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.